VCAM1 and lung carcinoma: Next, to investigate the effect of VCAM-1-D6 huMab on lung cancer cell invasion, we treated these cells cultured in the absence or presence of hTNFα with VCAM-1-D6 huMab, or IgG as a negative control, and then, we performed invasion assays.